Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Details:
SPY001 is an investigational novel half-life extended anti-α4β7 monoclonal antibody, which is being evaluated for the treatment of inflammatory bowel disease.
Lead Product(s): SPY001
Therapeutic Area: Gastroenterology Product Name: SPY001
Highest Development Status: Phase IProduct Type: Large molecule
Partner/Sponsor/Collaborator: Not Applicable
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable June 18, 2024